K
Karla Kerlikowske
Researcher at University of California, San Francisco
Publications - 408
Citations - 31869
Karla Kerlikowske is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Breast cancer & Mammography. The author has an hindex of 91, co-authored 380 publications receiving 28728 citations. Previous affiliations of Karla Kerlikowske include University of California, Davis & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
Jan A. Staessen,Jerzy Gasowski,Jerzy Gasowski,Ji G. Wang,Ji G. Wang,Lutgarde Thijs,Elly Den Hond,Jean-Pierre Boissel,John Coope,Tork Ekbom,François Gueyffier,Lisheng Liu,Karla Kerlikowske,Stuart J. Pocock,Robert Fagard +14 more
TL;DR: Drug treatment is justified in older patients with isolated systolic hypertension whose systolics blood pressure is 160 mm Hg or higher and in those with previous cardiovascular complications or wider pulse pressure, suggesting the coronary protection may have been underestimated.
Journal ArticleDOI
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Patricia A. Carney,Diana L. Miglioretti,Bonnie C. Yankaskas,Karla Kerlikowske,Robert D. Rosenberg,Carolyn M. Rutter,Berta M. Geller,Linn Abraham,Steven H. Taplin,Mark Dignan,Gary Cutter,Rachel Ballard-Barbash +11 more
TL;DR: The accuracy of screening mammography is best in older women and in women with fatty breasts, and the individual and combined effects of age, breast density, and HRT use on mammographic accuracy are examined.
Journal ArticleDOI
Efficacy of screening mammography. A meta-analysis.
Karla Kerlikowske,Deborah Grady,Deborah Grady,Susan M. Rubin,Christian Sandrock,Virginia L. Ernster +5 more
TL;DR: Screening mammography may be effective in reducing breast cancer mortality in women aged 40 to 49 years after 10 to 12 years of follow-up, but the same benefit could probably be achieved by beginning screening at menopause or 50 years of age.
Journal ArticleDOI
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
Deborah Grady,Tebeb Gebretsadik,Tebeb Gebretsadik,Tebeb Gebretsadik,Karla Kerlikowske,Karla Kerlikowske,Karla Kerlikowske,Virginia L. Ernster,Virginia L. Ernster,Virginia L. Ernster,Diana B. Petitti,Diana B. Petitti,Diana B. Petitti +12 more
TL;DR: Endometrial cancer risk increases substantially with long duration of unopposed estrogen use, and this increased risk persists for several years after discontinuation of estrogen therapy, similar to the increased risk of developing the disease.
Journal ArticleDOI
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities
Rebecca Smith-Bindman,Karla Kerlikowske,Vickie A. Feldstein,Leslee L. Subak,Juergen Scheidler,Mark R. Segal,Richard J. Brand,Deborah Grady +7 more
TL;DR: Endovaginal ultrasound has a high sensitivity for detecting endometrial cancer and otherendometrial disease and can reliably identify postmenopausal women with vaginal bleeding who are highly unlikely to have significant endometrian disease so that endometri sampling may be unnecessary.